Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orchestra BioMed Holdings (OBIO) Treasury Shares: 2022-2024

Historic Treasury Shares for Orchestra BioMed Holdings (OBIO) over the last 3 years, with Dec 2024 value amounting to $2.1 million.

  • Orchestra BioMed Holdings' Treasury Shares rose 11.02% to $2.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.6 million, marking a year-over-year increase of 11.02%. This contributed to the annual value of $2.1 million for FY2024, which is 23.12% up from last year.
  • According to the latest figures from FY2024, Orchestra BioMed Holdings' Treasury Shares is $2.1 million, which was up 23.12% from $1.7 million recorded in FY2023.
  • Orchestra BioMed Holdings' 5-year Treasury Shares high stood at $2.1 million for FY2024, and its period low was $158,589 during FY2022.
  • In the last 3 years, Orchestra BioMed Holdings' Treasury Shares had a median value of $1.7 million in 2023 and averaged $1.3 million.
  • Data for Orchestra BioMed Holdings' Treasury Shares shows a peak YoY spiked of 972.72% (in 2023) over the last 5 years.
  • Yearly analysis of 3 years shows Orchestra BioMed Holdings' Treasury Shares stood at $158,589 in 2022, then soared by 972.72% to $1.7 million in 2023, then increased by 23.12% to $2.1 million in 2024.